FDA announces flurry of emergency authorizations for COVID-19 products

By LabPulse.com staff writers

July 2, 2020 -- The U.S. Food and Drug Administration (FDA) announced a flurry of emergency use authorizations (EUAs) for COVID-19 products, including reverse transcription polymerase chain reaction (RT-PCR) tests, ahead of the July Fourth holiday.

Cleared July 2

Cleared July 1

Cleared June 30

Cleared June 29


FDA tells labs to remove faulty coronavirus antibody tests from stock
The U.S. Food and Drug Administration (FDA) has advised labs not to use antibody tests for the novel coronavirus that have been found to have low performance...
Rapid POC tests perform well, ease Chagas disease screening
A combination of marketed rapid point-of-care (POC) diagnostics was useful in screening for Chagas disease in a study conducted in Bolivia. The results...

Copyright © 2020 LabPulse.com

Last Updated eh 7/6/2020 3:58:18 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current